Andrew Huberman· PhD
the other thing complicates the story is there has been no shortage of drugs that Target amalo that have seemed unsuccessful
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
the other thing complicates the story is there has been no shortage of drugs that Target amalo that have seemed unsuccessful
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we can actively reduce the plaque burden the amyloid plaque burden in your brain but it doesn't seem to have any effect on your cognitive outcomes
there are several studies where they've made some very good drugs that can you know decrease plaque burden in the brain but that doesn't seem to correlate with later cognitive cognitive functions and may have a high risk of of side effects